Skip to main content
. 2017 Mar 15;8(45):79147–79156. doi: 10.18632/oncotarget.16131

Figure 4. The ROC curve calculation for the L-2-ALNM nomogram applied to the validation group (n = 141).

Figure 4

The AUC is 0.849 (95% CI, 0.782 to 0.917).